This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Serum Institute of India: Delivering COVID-19 Vaccines
Sourabh Bhattacharya; Kalyan C. Chejarla; Romina Mathew; Ayush Gupta; Vishrut AnandCase IVEY-W27136-EService and Operations Management, StrategyThe Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, faced a unique challenge in the manufacture and distribution of COVID-19 vaccines to its major stakeholders. SII had COVID-19 vaccine manufacture and supply commitments to COVAX, a joint initiative ensuring equitable access to COVID-19 vaccines for all countries and a transfer technology (licensing) agreement with AstraZeneca PLC to supply its COVID-19 vaccine...Starting at €8.20